Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.

14
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000000W4
HKD
2.89
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
36.00
133.00
177.00
262.00
201.00
287.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-124.00
-135.00
-62.00
-39.00
-111.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-16.00
78.00
192.00
324.00
121.00
298.00
Cash Flow from Investing Activities
-25.00
-50.00
-112.00
-428.00
-56.00
-225.00
Cash Flow from Financing Activities
-109.00
-131.00
13.00
-121.00
857.00
-86.00
Net Cash Inflow / Outflow
-151.00
-103.00
93.00
-226.00
921.00
-12.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
36.8757192570224
941.160075940648
-905.00
-96.08%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-124.058894620789
1253.24314009317
-1,377.00
-109.90%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-16.014430685565
2695.2051390504
-2,711.00
-100.59%
Cash Flow from Investing Activities
-25.8935693346702
-807.706587315083
782.00
96.79%
Cash Flow from Financing Activities
-109.802952490472
-2278.51956967137
2,169.00
95.18%
Net Cash Inflow / Outflow
-151.368889646412
-372.775540839392
221.00
59.39%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.342062864295553
18.2454770966604
-18.00
-98.13%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -120.41% vs -59.17% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-16.01
78.47
-120.41%